Thoroughbred Financial Services’s Tandem Diabetes Care TNDM Stock Holding History

Thoroughbred Financial Services’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,968	Closed	-$694K	–	396
2022 Q1	$694K	Buy	5,968 +3,210	+116%	+$375K	0.11%	186
2021 Q4	$415K	Buy	2,758 +435	+19%	+$58.7K	0.09%	227
2021 Q3	$277K	Hold	2,323	–	–	0.07%	256
2021 Q2	$226K	Sell	2,323 -110	-5%	-$9.81K	0.06%	278
2021 Q1	$214K	Buy	2,433 +155	+7%	+$14.4K	0.06%	256
2020 Q4	$217K	Hold	2,278	–	–	0.07%	224
2020 Q3	$258K	Buy	2,278 +110	+5%	+$11.6K	0.1%	192
2020 Q2	$214K	Sell	2,168 -2,575	-54%	-$205K	0.09%	203
2020 Q1	$305K	Sell	4,743 -125	-3%	-$8.76K	0.11%	180
2019 Q4	$290K	Buy	+4,868	New	+$300K	0.1%	196

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Thoroughbred Financial Services's TNDM Position: Q2 2022 in Review

Thoroughbred Financial Services sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 5,968 shares — an estimated $694K sold.

Thoroughbred Financial Services first reported a position in TNDM in Q4 2019 and held it in 10 quarters. The position peaked at $694K in Q1 2022. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

Thoroughbred Financial Services reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
Thoroughbred Financial Services sold 5,968 Tandem Diabetes Care shares in Q2 2022, an estimated $694K.
Thoroughbred Financial Services first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 10 quarters.
Thoroughbred Financial Services's Tandem Diabetes Care position peaked at $694K in Q1 2022.
330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Thoroughbred Financial Services's 13F filing for Q2 2022, filed 3 Aug 2022.